4//SEC Filing
Grissinger Michael 4
Accession 0001104659-22-084764
CIK 0001781983other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:02 PM ET
Size
7.3 KB
Accession
0001104659-22-084764
Insider Transaction Report
Form 4
Grissinger Michael
Director
Transactions
- Award
Stock Option (right to Buy)
2022-07-28+29,575→ 29,575 totalExercise: $1.09Exp: 2032-07-28→ Common Stock (29,575 underlying) - Award
Common Stock
2022-07-28+5,995→ 5,995 total
Footnotes (2)
- [F1]These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- [F2]The option vests in full on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001757601
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 5:02 PM ET
- Size
- 7.3 KB